Autoimmune Diseases: Current Treatments, Unmet Needs, and Patient Recruitment

Report Overview

ISR identifies and explores the patterns and preferences surrounding the needs, treatments, and side-effects of patients living with autoimmune diseases. This report offers pharmaceutical, biotech, and service provider companies with an opportunity to position their product, enhance clinical development, and improve clinical trial patient recruitment. The report provides value to both commercial and clinical development decision-makers.

The following autoimmune diseases are included:

• Celiac disease
• Fibromyalgia
• Graves’ disease
• Hashimoto’s disease
• Lupus
• Multiple sclerosis
• Rheumatoid arthritis
• Ulcerative colitis

What you will learn:

• Prevalence of symptoms associated with each disease and the symptoms that cause the most difficulty
• Patient satisfaction with current abilities, the occurrence of pain, and how the disease affects everyday life
• How a patient’s socio-economic status and level of satisfaction with their condition/ treatment regimen affect their willingness to enroll in a clinical trial
• Trends in disease diagnosis
• Payment issues with insurance
• Patient interactions with physicians (PCPs andSpecialists) and the non-medical individuals they turn to the most for support

How you can use this report:

• Design your marketing and advertising plans to account for the current issues and unmet patient needs
• Understand patient willingness and hesitations around enrolling in a clinical trial to position enrollment in a positive way
• Consider symptom relief, medication side effects, cost, and many other factors when planning for research and development

Methodology:

208 patients in the United States with an autoimmune disease completed a 20-minute web-based quantitative survey conducted by ISR.